Protein researches closing in on the mystery of schizophrenia

April 11, 2014, University of Southern Denmark

(Medical Xpress)—Schizophrenia is a severe disease for which there is still no effective medical treatment. In an attempt to understand exactly what happens in the brain of a schizophrenic person, researchers from the University of Southern Denmark have analyzed proteins in the brains of rats that have been given hallucinogenic drugs. This may pave the way for new and better medicines.

Seven per cent of the adult population suffers from schizophrenia, and although scientists have tried for centuries to understand the disease, they still do not know what causes the disease or which physiological changes it causes in the body. Doctors cannot make the diagnosis by looking for specific physiological changes in the patient's blood or tissue, but have to diagnose from behavioral symptoms.

In an attempt to find the physiological signature of schizophrenia, researchers from the University of Southern Denmark conducted tests on rats, and they now believe that the signature lies in some specific, measurable proteins. Knowing these proteins and comparing their behaviour to proteins in the brains of not schizophrenic people may make it possible to develop more effective drugs.

It is extremely difficult to study brain activity in schizophrenic people, which is why researchers often use animal models in their strive to understand the mysteries of the schizophrenic brain. Rat brains resemble human brains in so many ways that it makes sense to study them if one wants to learn more about the human brain.

Schizophrenic symptoms in rats

The strong hallucinogenic drug phenocyclidine (PCP), also known as "angel's dust", provides a range of symptoms in people which are very similar to schizophrenia.

"When we give PCP to rats, the rats become valuable study objects for schizophrenia researchers," explains Ole Nørregaard Jensen, professor and head of the Department of Biochemistry and Molecular Biology.

Along with Pawel Palmowski, Adelina Rogowska-Wrzesinska and others, he is the author of a scientific paper about the discovery, published in the international Journal of Proteome Research.

Among the symptoms and reactions that can be observed in both humans and rats are changes in movement and reduced cognitive functions such as impaired memory, attention and learning ability.

"Scientists have studied PCP rats for decades, but until now no one really knew what was going on in the rat brains at the molecular level. We now present what we believe to be the largest proteomics data set to date," says Ole Nørregaard Jensen.

PCP is absorbed very quickly by the brain, and it only stays in the brain for a few hours. Therefore, it was important for researchers to examine the rats' brain cells soon after the rats were injected with the hallucinogenic drug.

"We could see changes in the proteins in the brain already after 15 minutes. And after 240 minutes, it was almost over," says Ole Nørregaard Jensen.

The University of Southern Denmark holds some of the world's most advanced equipment for studying proteins, and Ole Nørregaard Jensen and his colleagues used the university's so-called mass spectrometres for their studies.

352 proteins cause brain changes

"We found 2604 proteins, and in 352 of them, we saw changes that can be associated with the PCP injections. These 352 proteins will be extremely interesting to study in closer detail to see if they also alter in people with schizophrenia - and if that's the case, it will of course be interesting to try to develop a drug that can prevent the protein changes that lead to schizophrenia," says Ole Nørregaard Jensen about the discovery and the work that now lies ahead.

The 352 proteins in responded immediately when the animals were exposed to PCP. Roughly speaking, the drug made proteins turn on or off when they should not turn on and off. This started a chain reaction of other disturbances in the molecular network around the proteins, such as changes in metabolism and calcium balance.

"These 352 proteins are what causes the rats to change their behaviour - and the events are probably comparable to the devastating changes in a schizophrenic brain," explains Ole Nørregaard Jensen.

The protocol for studying rat brain proteins with mass spectrometry, developed by Ole Nørregaard Jensen and his colleagues, is not limited to studies - it can also be used to explore other diseases.

The research was a collaboration between the University of Southern Denmark, the Danish Technological Institute and NeuroSearch A/S.

Details about the experiment

Twelve rats were used for the experiment. Six received an injection with the hallucinogenic drug PCP (10 mg/kg body weight), and six were injected with a saline solution to serve as controls. After 15 minutes, the first two animals in each group were killed and within less than two minutes, samples of their brains (temporal lobes) were taken and quickly frozen in liquid nitrogen.

After 30 and 240 minutes, respectively, the same was done to other . All experiments were conducted in accordance with Danish and EU guides for the handling of laboratory animals. The collected tissue samples were then subjected to various mass spectrometric protein analyses. The analyses revealed differences in the phosphorylation of proteins indicating which proteins had been affected by the drug PCP.

Interpretation of the complex protein data set suggest that PCP affects a number of processes in cells and leads to changes in calcium balance in the , changes in the transport of substances into and out of cells, changes in cell metabolism and changes in the structure of the cell's internal skeleton, the cytoskeleton.

Explore further: New research shows extended exposure to caffeine and sucrose impacts behaviour and brain chemistry

More information: Acute Phencyclidine Treatment Induces Extensive and Distinct Protein Phosphorylation in Rat Frontal Cortex. Palmowski P, Rogowska-Wrzesinska A, Williamson J, Beck HC, Mikkelsen JD, Hansen HH, Jensen ON. J Proteome Res. 2014 Feb 24.

Related Stories

New research shows extended exposure to caffeine and sucrose impacts behaviour and brain chemistry

February 7, 2014
New research suggests the long-term consumption of caffeinated sugar-sweetened drinks in place of water can cause lasting changes to behaviour, having profound effects on brain chemistry.

Rats' brains may 'remember' odor experienced while under general anesthesia

March 18, 2014
Rats' brains may remember odors they were exposed to while deeply anesthetized, suggests research in rats published in the April issue of Anesthesiology.

New target explored for psychiatric drug development

January 29, 2014
(Medical Xpress)—In a surprising discovery, neuroscientists have found that a breakdown product of cholesterol in the brain may be a target for developing new drugs to treat schizophrenia and other mental illnesses.

With a little training, signs of schizophrenia are averted

August 22, 2012
Animals that literally have holes in their brains can go on to behave as normal adults if they've had the benefit of a little cognitive training in adolescence. That's according to new work in the August 23 Neuron, a Cell ...

Memory accuracy and strength can be manipulated during sleep

April 8, 2014
The sense of smell might seem intuitive, almost something you take for granted. But researchers from NYU Langone Medical Center have found that memory of specific odors depends on the ability of the brain to learn, process ...

Toward a molecular explanation for schizophrenia

December 30, 2013
Surprisingly little is known about schizophrenia. It was only recognized as a medical condition in the past few decades, and its exact causes remain unclear. Since there is no objective test for schizophrenia, its diagnosis ...

Recommended for you

Research reveals atomic-level changes in ALS-linked protein

January 18, 2018
For the first time, researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases ...

Fragile X finding shows normal neurons that interact poorly

January 18, 2018
Neurons in mice afflicted with the genetic defect that causes Fragile X syndrome (FXS) appear similar to those in healthy mice, but these neurons fail to interact normally, resulting in the long-known cognitive impairments, ...

How your brain remembers what you had for dinner last night

January 17, 2018
Confirming earlier computational models, researchers at University of California San Diego and UC San Diego School of Medicine, with colleagues in Arizona and Louisiana, report that episodic memories are encoded in the hippocampus ...

Recording a thought's fleeting trip through the brain

January 17, 2018
University of California, Berkeley neuroscientists have tracked the progress of a thought through the brain, showing clearly how the prefrontal cortex at the front of the brain coordinates activity to help us act in response ...

Midbrain 'start neurons' control whether we walk or run

January 17, 2018
Locomotion comprises the most fundamental movements we perform. It is a complex sequence from initiating the first step, to stopping when we reach our goal. At the same time, locomotion is executed at different speeds to ...

A 'touching sight': How babies' brains process touch builds foundations for learning

January 16, 2018
Touch is the first of the five senses to develop, yet scientists know far less about the baby's brain response to touch than to, say, the sight of mom's face, or the sound of her voice.


Adjust slider to filter visible comments by rank

Display comments: newest first

3 / 5 (3) Apr 12, 2014
Given that "schizophrenia" actually means something and is not code for "too hard basket" there is a Niacin skin reaction test that causes "normal" people to blush bright red- but has no reaction on people stigmatised with "schizophrenia"
Given the strong co-relation between genius and related family members with the condition, how about this as an explanation- that the condition is the result of evolution pushing the boundaries of what is possible with the wetware available? After all we are a one trick pony- our survival relies on on only one organ. Is it not possible that in an effort to get the evolutionary edge on the competition we go one step too far? In other words it is not a "disease" to be cured but a condition to be managed.
It is the price paid for our humanity. Paid for by our kin.
3 / 5 (2) Apr 12, 2014
Serious error. Schizophrenia strikes ONE percent of the world's population, Not "7%". If it were 7%, the entire health system would have collapsed long ago -- not to mention economic catastrophe.
1 / 5 (1) Apr 14, 2014
Given the strong co-relation between genius and related family members with the condition, how about this as an explanation- that the condition is the result of evolution pushing the boundaries of what is possible with the wetware available?

There are some arguments that schizophrenia's common because of heterozygote advantage - there's circumstantial evidence that people with a few alleles associated with schizophrenia might be more creative or have better social skills than average. (Reviewed on p. 4 here, along with other evolutionary explanations: http://www.tweeli...2013.pdf )

But none of the evidence of selection for schizophrenia is particularly strong. I think a better explanation is that, because so many genes are involved in normal brain function, de novo mutations that cause schizophrenia are just really common. (http://www.nature...162.html

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.